{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:14:27Z","timestamp":1776741267551,"version":"3.51.2"},"reference-count":23,"publisher":"Japanese Association of Rehabilitation Medicine","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PRM"],"published-print":{"date-parts":[[2024]]},"DOI":"10.2490\/prm.20240016","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T22:19:51Z","timestamp":1713997191000},"page":"n\/a","source":"Crossref","is-referenced-by-count":2,"title":["Validity of the Functional Classification of the Upper Extremities for Duchenne Muscular Dystrophy"],"prefix":"10.2490","volume":"9","author":[{"given":"Yuta","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"},{"name":"Department of Rehabilitation Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"},{"name":"Department of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"},{"name":"Department of Rehabilitation Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"},{"name":"Department of Rehabilitation Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Komaki","sequence":"additional","affiliation":[{"name":"Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"},{"name":"Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Tokai University School of Medicine, Hiratsuka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Abo","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1338","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, DMD Care Considerations Working Group: Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018;17:251\u2013267. PMID:29395989, DOI:10.1016\/S1474-4422(18)30024-3","DOI":"10.1016\/S1474-4422(18)30024-3"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Komaki H, Takeshima Y, Matsumura T, Ozasa S, Funato M, Takeshita E, Iwata Y, Yajima H, Egawa Y, Toramoto T, Tajima M, Takeda S: Viltolarsen in Japanese Duchenne muscular dystrophy patients: a phase 1\/2 study. Ann Clin Transl Neurol 2020;7:2393\u20132408. PMID:33285037, DOI:10.1002\/acn3.51235","DOI":"10.1002\/acn3.51235"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Elangkovan N, Dickson G: Gene therapy for Duchenne muscular dystrophy. J Neuromuscul Dis 2021;8:S303\u2013S316. PMID:34511510, DOI:10.3233\/JND-210678","DOI":"10.3233\/JND-210678"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Mercuri E, Mayhew A, Muntoni F, Messina S, Straub V, Van Ommen GJ, Voit T, Bertini E, Bushby K, TREAT-NMD Neuromuscular Network: Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops: TREAT-NMD\/ENMC Workshop on outcome measures, 12th\u201313th May 2007, Naarden, The Netherlands; TREAT-NMD Workshop on outcome measures in experimental trials for DMD, 30th June\u20131st July 2007, Naarden, The Netherlands; Conjoint Institute of Myology TREAT-NMD Meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord 2008;18:894\u2013903. PMID:18818076, DOI:10.1016\/j.nmd.2008.07.003","DOI":"10.1016\/j.nmd.2008.07.003"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Russell DJ, Rosenbaum PL, Cadman DT, Gowland C, Hardy S, Jarvis S: The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989;31:341\u2013352. PMID:2753238, DOI:10.1111\/j.1469-8749.1989.tb04003.x","DOI":"10.1111\/j.1469-8749.1989.tb04003.x"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. B\u00e9rard C, Payan C, Hodgkinson I, Fermanian J, The MFM Collaborative Study Group: A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord 2005;15:463\u2013470. PMID:16106528, DOI:10.1016\/j.nmd.2005.03.004","DOI":"10.1016\/j.nmd.2005.03.004"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Vignos PJ, Jr, Spencer GE, Jr, Archibald KC: Management of progressive muscular dystrophy in childhood. JAMA 1963;184:89\u201396. PMID:13997180, DOI:10.1001\/jama.1963.03700150043007","DOI":"10.1001\/jama.1963.03700150043007"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Elfring GL, Atkinson L, Reha A, Hirawat S, Miller LL: The 6\u2010minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010;41:500\u2013510. PMID:19941337, DOI:10.1002\/mus.21544","DOI":"10.1002\/mus.21544"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Mazzone E, Martinelli D, Berardinelli A, Messina S, D\u2019Amico A, Vasco G, Main M, Doglio L, Politano L, Cavallaro F, Frosini S, Bello L, Carlesi A, Bonetti AM, Zucchini E, Sanctis RD, Scutifero M, Bianco F, Rossi F, Motta MC, Sacco A, Donati MA, Mongini T, Pini A, Battini R, Pegoraro E, Pane M, Pasquini E, Bruno C, Vita G, Waure C, Bertini E, Mercuri E: North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord 2010;20:712\u2013716. PMID:20634072, DOI:10.1016\/j.nmd.2010.06.014","DOI":"10.1016\/j.nmd.2010.06.014"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Henricson EK, Abresch RT, Cnaan A, Hu F, Duong T, Arrieta A, Han J, Escolar DM, Florence JM, Clemens PR, Hoffman EP, McDonald CM, CINRG Investigators: The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures. Muscle Nerve 2013;48:55\u201367. PMID:23649481, DOI:10.1002\/mus.23808","DOI":"10.1002\/mus.23808"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Mazzone ES, Vasco G, Palermo C, Bianco F, Galluccio C, Ricotti V, Castronovo AD, Mauro MS, Pane M, Mayhew A, Mercuri E: A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy. Dev Med Child Neurol 2012;54:879\u2013885. PMID:22713125, DOI:10.1111\/j.1469-8749.2012.04345.x","DOI":"10.1111\/j.1469-8749.2012.04345.x"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Mayhew A, Mazzone ES, Eagle M, Duong T, Ash M, Decostre V, Vandenhauwe M, Klingels K, Florence J, Main M, Bianco F, Henrikson E, Servais L, Campion G, Vroom E, Ricotti V, Goemans N, Mcdonald C, Mercuri E, Performance of the Upper Limb Working Group: Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol 2013;55:1038\u20131045. PMID:23902233, DOI:10.1111\/dmcn.12213","DOI":"10.1111\/dmcn.12213"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ: Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981;4:186\u2013197. PMID:7017401, DOI:10.1002\/mus.880040304","DOI":"10.1002\/mus.880040304"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Pane M, Mazzone ES, Fanelli L, De Sanctis R, Bianco F, Sivo S, D\u2019Amico A, Messina S, Battini R, Scutifero M, Petillo R, Frosini S, Scalise R, Vita G, Bruno C, Pedemonte M, Mongini T, Pegoraro E, Brustia F, Gardani A, Berardinelli A, Lanzillotta V, Viggiano E, Cavallaro F, Sframeli M, Bello L, Barp A, Bonfiglio S, Rolle E, Colia G, Catteruccia M, Palermo C, D\u2019Angelo G, Pini A, Iotti E, Gorni K, Baranello G, Morandi L, Bertini E, Politano L, Sormani M, Mercuri E: Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. Neuromuscul Disord 2014;24:201\u2013206. PMID:24440357, DOI:10.1016\/j.nmd.2013.11.014","DOI":"10.1016\/j.nmd.2013.11.014"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Davoli GB, Cardoso J, Silva GC, Moreira RF, Mattiello-Sverzut AC: Instruments to assess upper\u2010limb function in children and adolescents with neuromuscular diseases: a systematic review. Dev Med Child Neurol 2021;63:1030\u20131037. PMID:33834485, DOI:10.1111\/dmcn.14887","DOI":"10.1111\/dmcn.14887"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Gandolla M, Antonietti A, Longatelli V, Biffi E, Diella E, Delle Fave M, Rossini M, Molteni F, D\u2019Angelo G, Bocciolone M, Pedrocchi A: Test\u2013retest reliability of the Performance of Upper Limb (PUL) module for muscular dystrophy patients. PLoS One 2020;15:e0239064. PMID:32986757, DOI:10.1371\/journal.pone.0239064","DOI":"10.1371\/journal.pone.0239064"},{"key":"17","unstructured":"17. Matsuka Y: Natural course and evaluation of the upper extremities function in Duchenne muscular dystrophy [in Japanese]. Sogo Rehabil 1983;11:245\u2013252."},{"key":"18","unstructured":"18. Madokoro N, Otsuka T, Sakai K, Mochizuki H, Kawai M: The functional classification of the upper extremities in Duchenne muscular dystrophy: the new evaluation of finger functions of the most severe DMD patients [in Japanese]. Sogo Rehabil 2009;37:347\u2013356."},{"key":"19","unstructured":"19. Madokoro N, Otsuka T, Tanitabe K: A study about the reliability of the Functional Classification of the Upper Extremities for Duchenne muscular dystrophy patients and their environmental control switch options based on the new classification [in Japanese]. Iryo 2010;64:452\u2013459."},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Jung IY, Chae JH, Park SK, Kim JH, Kim JY, Kim SJ, Bang MS: The correlation analysis of functional factors and age with Duchenne muscular dystrophy. Ann Rehabil Med 2012;36:22\u201332. PMID:22506232, DOI:10.5535\/arm.2012.36.1.22","DOI":"10.5535\/arm.2012.36.1.22"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Broomfield J, Hill M, Guglieri M, Crowther M, Abrams K: Life expectancy in Duchenne muscular dystrophy: reproduced individual patient data meta-analysis. Neurology 2021;97:e2304\u2013e2314. PMID:34645707, DOI:10.1212\/WNL.0000000000012910","DOI":"10.1212\/WNL.0000000000012910"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Bello L, Gordish-Dressman H, Morgenroth LP, Henricson EK, Duong T, Hoffman EP, Cnaan A, McDonald CM, CINRG Investigators: Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study. Neurology 2015;85:1048\u20131055. PMID:26311750, DOI:10.1212\/WNL.0000000000001950","DOI":"10.1212\/WNL.0000000000001950"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Markati T, Oskoui M, Farrar MA, Duong T, Goemans N, Servais L: Emerging therapies for Duchenne muscular dystrophy. Lancet Neurol 2022;21:814\u2013829. PMID:35850122, DOI:10.1016\/S1474-4422(22)00125-9","DOI":"10.1016\/S1474-4422(22)00125-9"}],"container-title":["Progress in Rehabilitation Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/9\/0\/9_20240016\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:03:36Z","timestamp":1714194216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/9\/0\/9_20240016\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":23,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2490\/prm.20240016","relation":{},"ISSN":["2432-1354"],"issn-type":[{"value":"2432-1354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"20240016"}}